Overall Fundamental outlook

Business Operations:

Sector: Healthcare
Industry: Diagnostics & Research

Dr. Lal PathLabs Limited operates laboratories for carrying out pathological investigations in India and internationally. The company provides pathological investigations of various branches of bio-chemistry, hematology, histopathology, microbiology, electrophoresis, immuno-chemistry, immunology, virology, cytology, and other pathological and radiological investigations. It also offers training programs. The company was founded in 1949 and is based in Gurugram, India.

Revenue projections:

Revenue projections for LALPATHLAB
Revenue projections for LALPATHLAB

LALPATHLAB's revenue projections indicate a decrease from last year's performance, which could lead to investor caution. A fall in revenue is likely to negatively impact the company's profitability, causing concern for shareholders who may view this as a signal of declining financial health.

Financial Ratios:

currentRatio 0.00000
forwardPE 46.10058
debtToEquity 9.75300
earningsGrowth 0.18600
revenueGrowth 0.10700
grossMargins 0.57712
operatingMargins 0.19859
trailingEps 49.99000
forwardEps 29.38000

With positive earnings and revenue growth, LALPATHLAB is on a path to expand its business. This strong financial performance suggests the company will continue to grow, as increasing profits and revenue highlight a healthy outlook.
Dr. Lal PathLabs Limited's forward EPS being lower than its trailing EPS suggests that the company's earnings may decline in the current year. This could indicate financial challenges ahead for the company.

Price projections:

Price projections for LALPATHLAB
Price projections for LALPATHLAB



Insider Transactions:

Insider Transactions for LALPATHLAB
Insider Transactions for LALPATHLAB


There were 40 Dr. Lal PathLabs Limited sales transactions, at market price of 3139.3624877929688.Throughout the period under consideration, there were no sell transactions.LALPATHLAB's current price levels are seeing more buying activity than selling, which might indicate a bullish sentiment. Investors appear to be confident, interpreting the buying trend as a sign of positive expectations for the stock's future performance.

Recommendation changes over time:

Recommendations trend for LALPATHLAB
Recommendations trend for LALPATHLAB


Analysts' buy bias for Dr. Lal PathLabs Limited signals that the stock is considered a favorable investment. This outlook might prompt investors to allocate funds to Dr. Lal PathLabs Limited, seeing it as a solid and profitable choice to park their money and potentially benefit from the company's long-term growth.